rutecarpine has been researched along with epiglucan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alsalih, L; Balcom-Luker, S; Bradfield, CJ; Ferrer, M; Fraser, IDC; John, SP; Lipsey, C; Markowitz, TE; Pierre, MJ; Singh, A; Smelkinson, M; Song, J; Sun, J; Traore, Z | 1 |
1 other study(ies) available for rutecarpine and epiglucan
Article | Year |
---|---|
Small-molecule screening identifies Syk kinase inhibition and rutaecarpine as modulators of macrophage training and SARS-CoV-2 infection.
Topics: beta-Glucans; COVID-19 Drug Treatment; Cytokines; Humans; Indole Alkaloids; Lipopolysaccharides; Macrophages; Quinazolinones; SARS-CoV-2; Syk Kinase; Tumor Necrosis Factor-alpha | 2022 |